{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "8889140", "primarysourcecountry": "CA", "occurcountry": "CA", "transmissiondateformat": "102", "transmissiondate": "20130627", "serious": "1", "seriousnesscongenitalanomali": "1", "receivedateformat": "102", "receivedate": "20121106", "receiptdateformat": "102", "receiptdate": "20121106", "fulfillexpeditecriteria": "1", "companynumb": "CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2012-CN-02215CN", "duplicate": "1", "reportduplicate": { "duplicatesource": "BOEHRINGER INGELHEIM", "duplicatenumb": "CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2012-CN-02215CN" }, "primarysource": { "reportercountry": "CA", "qualification": "2" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "0", "patientonsetageunit": "801", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "16.0", "reactionmeddrapt": "Neural tube defect", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "16.0", "reactionmeddrapt": "Spina bifida", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "16.0", "reactionmeddrapt": "Lipoma", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "CATAPRES", "drugauthorizationnumb": "17-407", "drugstructuredosagenumb": ".2", "drugstructuredosageunit": "003", "drugadministrationroute": "064", "drugindication": "MATERNAL EXPOSURE DURING PREGNANCY" }, { "drugcharacterization": "2", "medicinalproduct": "LYRICA", "drugstructuredosagenumb": "150", "drugstructuredosageunit": "003", "drugadministrationroute": "064", "drugindication": "MATERNAL EXPOSURE DURING PREGNANCY", "openfda": { "application_number": [ "NDA021446", "NDA022488" ], "brand_name": [ "LYRICA" ], "generic_name": [ "PREGABALIN" ], "manufacturer_name": [ "Parke-Davis Div of Pfizer Inc", "Viatris Specialty LLC" ], "product_ndc": [ "0071-1018", "0071-1012", "0071-1013", "0071-1014", "0071-1015", "0071-1016", "0071-1017", "0071-1019", "0071-1020", "58151-236", "58151-237", "58151-238", "58151-239", "58151-240", "58151-241", "58151-243", "58151-242", "58151-244" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "PREGABALIN" ], "rxcui": [ "483438", "483440", "483442", "483444", "483446", "483448", "483450", "577127", "607018", "607020", "607022", "607024", "607026", "607028", "607033", "607038", "898715", "898718" ], "spl_id": [ "e7c79058-03ba-4e7f-9a31-9ec5ce245161", "1c2af07d-faf4-4fc7-b724-c5166746956d" ], "spl_set_id": [ "60185c88-ecfd-46f9-adb9-b97c6b00a553", "d4734e7d-5079-455e-8ff5-8f4539c998a9" ], "package_ndc": [ "0071-1012-68", "0071-1013-41", "0071-1013-68", "0071-1014-41", "0071-1014-68", "0071-1015-41", "0071-1015-68", "0071-1016-41", "0071-1016-68", "0071-1017-68", "0071-1019-68", "0071-1018-68", "0071-1020-01", "58151-236-77", "58151-237-32", "58151-237-88", "58151-237-77", "58151-238-32", "58151-238-88", "58151-238-77", "58151-239-32", "58151-239-88", "58151-239-77", "58151-240-32", "58151-240-88", "58151-240-77", "58151-241-77", "58151-243-77", "58151-242-77", "58151-244-35" ], "unii": [ "55JG375S6M" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ZYTRAM XL", "drugstructuredosagenumb": "150", "drugstructuredosageunit": "003", "drugadministrationroute": "064", "drugindication": "MATERNAL EXPOSURE DURING PREGNANCY" }, { "drugcharacterization": "2", "medicinalproduct": "SYNTHROID", "drugadministrationroute": "064", "drugindication": "MATERNAL EXPOSURE DURING PREGNANCY", "openfda": { "application_number": [ "NDA021402" ], "brand_name": [ "SYNTHROID" ], "generic_name": [ "LEVOTHYROXINE SODIUM" ], "manufacturer_name": [ "AbbVie Inc." ], "product_ndc": [ "0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LEVOTHYROXINE SODIUM" ], "rxcui": [ "892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282" ], "spl_id": [ "b85ab7fa-ba96-43cd-b736-44b3924e644c" ], "spl_set_id": [ "1e11ad30-1041-4520-10b0-8f9d30d30fcc" ], "package_ndc": [ "0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19" ], "unii": [ "9J765S329G" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CESAMET", "drugstructuredosagenumb": ".5", "drugstructuredosageunit": "003", "drugadministrationroute": "064", "drugindication": "MATERNAL EXPOSURE DURING PREGNANCY", "openfda": { "application_number": [ "NDA018677" ], "brand_name": [ "CESAMET" ], "generic_name": [ "NABILONE" ], "manufacturer_name": [ "Bausch Health US LLC" ], "product_ndc": [ "0187-1231" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "NABILONE" ], "rxcui": [ "104885", "311891" ], "spl_id": [ "c8ba6520-445a-4934-85f4-6f706cb21585" ], "spl_set_id": [ "83c7ac15-ece9-47de-b83c-d575544fa449" ], "package_ndc": [ "0187-1231-50" ], "nui": [ "N0000175782", "M0003267" ], "pharm_class_epc": [ "Cannabinoid [EPC]" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "unii": [ "2N4O9L084N" ] } } ] } } ] }